Literature DB >> 182899

Fc receptor-mediated inhibition of murine B-lymphocyte activation.

J L Ryan, P A Henkart.   

Abstract

Immobilized antigen-antibody complexes are able to inhibit the mitogenic response of murine spleen cells to the B-cell mitogen 8-bromo-3',5'-cyclic guanosine monophosphoric acid. This this inhibition is dependent on intact Fc fragments in the immobilized complexes. Soluble complexes do not mediate this inhibition. When lipopolysaccharide (lps) activation of B cells was studied, it was found that the mitogenic response was inhibited at all times tested between 2 and 7 days of culture. Also, the LPS-induced mitogenesis of nude spleen cells was inhibited by immobilized complexes, indicating that suppressor T cells probably play no significant role in the inhibition. Immobilized complexes inhibit polyclonal antibody responses in a serum-free system and in the presence of normal mouse serum, but are unable to inhibit in the presence of fetal calf serum (FCS). If nu/nu spleen cells are used, however, the FCS does not block the ability of the complexes to inhibit the polyclonal response. It is suggested that that antigen-antibody complexes under appropriate conditions may bind to B lymphocytes via their Fc receptors and trigger a central "off" signal which blocks proliferation and consequently antibody production.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182899      PMCID: PMC2190415          DOI: 10.1084/jem.144.3.768

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Sera and the in vitro induction of immune responses. I. Bacterial contamination and the generation of good fetal bovine sera.

Authors:  S M Shiigi; R I Mishell
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

2.  Specific mitogenic activity of 8-Br-guanosine 3',5'-monophosphate (Br-cyclic GMP) on B lymphocytes.

Authors:  Y Weinstein; S Segal; K L Melmon
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

3.  Regulation of the immune response. IV. Antibody-mediated suppression of the immune response to haptens and heterologous erythrocyte antigens in vitro.

Authors:  J W Kappler; A van der Hoven; U Dharmarajan; M Hoffmann
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

4.  Inhibition of lymphocyte mitogenesis by immobilized antigen-antibody complexes.

Authors:  J L Ryan; R D Arbeit; H B Dickler; P A Henkart
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

5.  Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. II. Evidence for separate stimulatory and inhibitory cells.

Authors:  R W Dutton
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

6.  The Fc receptor on thymus-derived lymphocytes: II. Mitogen responsiveness of T lymphocytes bearing the Fc receptor.

Authors:  R D Stout; L A Herzenberg
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

7.  The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis.

Authors:  J Watson
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

8.  Role of C'3 and Fc receptors in B-lymphocyte activation.

Authors:  G Möller; A Coutinho
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

9.  Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes.

Authors:  C L Anderson; H M Grey
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

10.  The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule.

Authors:  J Andersson; F Melchers; C Galanos; O Lüderitz
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

View more
  11 in total

1.  Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

Authors:  E C Böttger; T Hoffmann; U Hadding; D Bitter-Suermann
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

2.  Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation.

Authors:  W Stohl
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

3.  Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells.

Authors:  D A Horwitz; K Juul-Nielsen
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

4.  IgD-Fc receptors on normal and neoplastic human B lymphocytes.

Authors:  R A Rudders; J Andersen
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

Review 5.  Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme.

Authors:  Marta Pablos; Elena Casanueva-Álvarez; Carlos M González-Casimiro; Beatriz Merino; Germán Perdomo; Irene Cózar-Castellano
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-27       Impact factor: 6.055

6.  Bovine milk IgG, but not serum IgG, inhibits pokeweed mitogen-induced antibody secretion by human peripheral blood mononuclear cells.

Authors:  A Kulczycki; G S Nash; M J Bertovich; H D Burack; R P MacDermott
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

7.  Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy.

Authors:  A Durandy; A Fischer; C Griscelli
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.

Authors:  E M Carvalho; O Bacellar; A Barral; R Badaro; W D Johnson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  B-lymphocytes activation by the Fc region of IgG.

Authors:  M A Berman; W O Weigle
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  Neutral protease secretion by human monocytes. Effect of surface-bound immune complexes.

Authors:  C G Ragsdale; W P Arend
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.